awemond

What about the pricing in developing countries - are pharmaceuticals a similar price in all countries? If so, is there any way to make pharmaceuticals for diseases that affect many people without a lot of spending power more affordable, while still allowing pharmaceutical companies to recover their R&D costs?

Have you come across any practices/policies/laws that, if changed, could help lower the cost of branded pharmaceuticals?

Part of what drives R&D costs so high is that often multiple pharmaceutical companies are chasing similar leads and repeat the same tests and trials that others have already tried and deemed unsuccessful. Why isn't there more transparency and sharing about unsuccessful leads so that R&D money isn't wasted on repeating failures?